2010
DOI: 10.1111/j.1471-4159.2009.06551.x
|View full text |Cite
|
Sign up to set email alerts
|

Nicotine self‐administration diminishes stress‐induced norepinephrine secretion but augments adrenergic‐responsiveness in the hypothalamic paraventricular nucleus and enhances adrenocorticotropic hormone and corticosterone release

Abstract: J. Neurochem. (2010) 112, 1327–1337. Abstract Chronic nicotine self‐administration augments the thalamo‐pituitary‐adrenal (HPA) responses to stress. Altered neuropeptide expression within corticotropin‐releasing factor (CRF) neurons in the hypothalamic paraventricular nucleus (PVN) contributes to this enhanced HPA response to stress. Herein, we determined the role of norepinephrine, a primary regulator of CRF neurons, in the responses to footshock during nicotine self‐administration. On day 12–15 of self‐admin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
17
3

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 35 publications
3
17
3
Order By: Relevance
“…However, nicotine was previously reported to acutely elevate corticosterone secretion, an effect that desensitizes after repeated injections or long-term self-administration of the drug [96,97]. Furthermore, chronic nicotine self-administration was shown to augment corticosterone responses to novel stressors such as foot shock stress [96,98]. Therefore, it seems unlikely that nicotine can reduce corticosterone levels in our A animals.…”
Section: Discussionmentioning
confidence: 50%
“…However, nicotine was previously reported to acutely elevate corticosterone secretion, an effect that desensitizes after repeated injections or long-term self-administration of the drug [96,97]. Furthermore, chronic nicotine self-administration was shown to augment corticosterone responses to novel stressors such as foot shock stress [96,98]. Therefore, it seems unlikely that nicotine can reduce corticosterone levels in our A animals.…”
Section: Discussionmentioning
confidence: 50%
“…Although higher doses of nicotine can act as chronic stressors (Yu & Sharp, 2010), the doses reviewed here, which match the levels reported in human smokers (Davis et al, 2005), selectively alter learning via the modulation of hippocampal and medial prefrontal signaling, rather than by affecting general stress levels. Additionally, this work demonstrates that fear conditioning is sensitive to the different patterns of nicotine exposure that are observed in human smokers and patients diagnosed with PTSD.…”
Section: Nicotine and Fear Conditioningmentioning
confidence: 66%
“…Importantly, at the these doses, nicotine does not affect delay fear conditioning, regardless of conditioning strength (Gould & Higgins, 2003), suggesting that nicotine enhances contextual and trace conditioning via the enhancement of learning, rather than altering anxiety or stress. However, it should be noted that higher doses of nicotine are anxiogenic and can act as stressors (Yu & Sharp, 2010). Interestingly, nicotine can also enhance cued extinction after delay fear conditioning (Elias, Gulick, Wilkinson, & Gould, 2010), a task that relies on cortical substrates similar to those that support the acquisition of trace fear conditioning (Stafford, Raybuck, Ryabinin, & Lattal, 2012).…”
Section: Nicotine and Fear Conditioningmentioning
confidence: 99%
“…Interestingly, conditioned preference for morphine is absent in DbH knock-out mice in which NE synthesis is interrupted, but preference is restored if DbH is rescued to restore NA signaling within and from the NTS, but not the LC (176). Repeated nicotine self-administration increases NA receptor sensitivity in the PVN and also enhances HPA function (290). Collectively, it seems that NA signaling from the A2 cell group to the hypothalamus and limbic forebrain contributes to mechanisms that support drug seeking and self-administration, increased anxiety during drug abstinence, altered reward processing (i.e., dysphoria), and the general relationship between the use of mood-altering drugs and mood disorders (12, 38, 78, 131, 176, 244).…”
Section: A2 Neurons In Drug Use and Dependencementioning
confidence: 93%